Structures by: Karanam M.
Total: 35
C22H20O4
C22H20O4
RSC Adv. (2014) 4, 36 18904
a=17.4674(16)Å b=22.482(2)Å c=9.5117(9)Å
α=90° β=90.222(6)° γ=90°
C28H20O6
C28H20O6
RSC Adv. (2014) 4, 36 18904
a=11.383(3)Å b=11.543(3)Å c=17.587(5)Å
α=90° β=97.626(13)° γ=90°
C28H24O4
C28H24O4
RSC Adv. (2014) 4, 36 18904
a=8.867(3)Å b=16.757(5)Å c=14.800(5)Å
α=90° β=91.210(7)° γ=90°
C24H22O4
C24H22O4
RSC Adv. (2014) 4, 36 18904
a=8.903(4)Å b=23.110(10)Å c=10.380(5)Å
α=90° β=108.380(10)° γ=90°
C24H20O4
C24H20O4
RSC Adv. (2014) 4, 36 18904
a=4.856(3)Å b=53.09(4)Å c=7.510(5)Å
α=90° β=93.902(18)° γ=90°
C24H24O4
C24H24O4
RSC Adv. (2014) 4, 36 18904
a=5.975(7)Å b=10.756(13)Å c=16.56(2)Å
α=73.702(14)° β=87.212(14)° γ=83.25(2)°
C24H24O5
C24H24O5
RSC Adv. (2014) 4, 36 18904
a=20.0985(11)Å b=8.3800(4)Å c=12.1731(6)Å
α=90° β=91.639(2)° γ=90°
C26H28O6
C26H28O6
RSC Adv. (2014) 4, 36 18904
a=18.8390(8)Å b=13.5066(6)Å c=9.0088(3)Å
α=90° β=90° γ=90°
C26H24O8
C26H24O8
RSC Adv. (2014) 4, 36 18904
a=8.9306(5)Å b=13.0866(8)Å c=19.8566(11)Å
α=90° β=90° γ=90°
C30H32O4
C30H32O4
RSC Adv. (2014) 4, 36 18904
a=15.205(6)Å b=16.280(7)Å c=10.936(5)Å
α=90° β=107.697(9)° γ=90°
C30H32O5
C30H32O5
RSC Adv. (2014) 4, 36 18904
a=8.6914(9)Å b=12.4846(14)Å c=25.241(3)Å
α=77.626(3)° β=87.992(4)° γ=79.519(4)°
C22H23NO5
C22H23NO5
RSC Adv. (2014) 4, 36 18904
a=10.4541(10)Å b=17.4437(17)Å c=11.0894(10)Å
α=90° β=104.244(5)° γ=90°
C26H30O4S
C26H30O4S
RSC Adv. (2014) 4, 36 18904
a=8.9442(9)Å b=9.7734(10)Å c=14.2491(12)Å
α=85.521(5)° β=75.471(5)° γ=75.776(5)°
C24H26O5S
C24H26O5S
RSC Adv. (2014) 4, 36 18904
a=9.5532(5)Å b=24.2453(13)Å c=9.5232(4)Å
α=90° β=90° γ=90°
C47H36ClF2IrNP2
C47H36ClF2IrNP2
Dalton transactions (Cambridge, England : 2003) (2012) 41, 31 9276-9279
a=32.2085(4)Å b=12.26820(10)Å c=9.68300(10)Å
α=90° β=90° γ=90°
2-(2,4-difluorophenyl)-1,3-di(1H-1,2,4-triazol-1-yl)propan-2-ol
C13H12F2N6O
Crystal Growth & Design (2012) 12, 1 240
a=12.9282(9)Å b=6.0241(5)Å c=34.834(3)Å
α=90° β=90° γ=90°
Fluconazole
C13H12F2N6O
Crystal Growth & Design (2012) 12, 1 240
a=6.6989(4)Å b=27.3867(19)Å c=15.2901(11)Å
α=90° β=90.319(3)° γ=90°
Fluconazole
C13H12F2N6O
Crystal Growth & Design (2012) 12, 1 240
a=27.4726(9)Å b=10.9196(4)Å c=22.3424(12)Å
α=90° β=125.337(2)° γ=90°
Fluconazole
C13H12F2N6O
Crystal Growth & Design (2012) 12, 1 240
a=10.9186(9)Å b=22.3367(18)Å c=22.3619(17)Å
α=90° β=90° γ=90°
1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-3- quinolonecarboxylic acid
C19H22FN3O3
Crystal Growth & Design (2013) 13, 4 1626
a=13.9345(4)Å b=6.8516(2)Å c=25.1563(5)Å
α=90° β=133.7980(10)° γ=90°
1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-3- quinolonecarboxylic acid hexahydrate
C19H22FN3O3,6(H2O)
Crystal Growth & Design (2013) 13, 4 1626
a=8.037(3)Å b=11.030(8)Å c=13.186(8)Å
α=79.170(5)° β=78.873(10)° γ=88.102(10)°
C19H23FN3O3,C2H4O2,C2H3O2,H2O
C19H23FN3O3,C2H4O2,C2H3O2,H2O
Crystal Growth & Design (2013) 13, 4 1626
a=7.2779(4)Å b=12.2704(8)Å c=14.5883(9)Å
α=95.722(4)° β=99.508(4)° γ=102.931(4)°
C19H23FN3O3,C4H3O4
C19H23FN3O3,C4H3O4
Crystal Growth & Design (2013) 13, 4 1626
a=7.0956(7)Å b=12.4527(12)Å c=13.0720(15)Å
α=87.337(7)° β=75.913(7)° γ=84.671(7)°
C19H23FN3O3,3(H2O),CO2
C19H23FN3O3,3(H2O),CO2
Crystal Growth & Design (2013) 13, 4 1626
a=7.0198(10)Å b=9.3767(19)Å c=17.249(4)Å
α=85.137(3)° β=83.594(3)° γ=73.497(4)°
C19H21FN3O3,H4N,3(H2O)
C19H21FN3O3,H4N,3(H2O)
Crystal Growth & Design (2013) 13, 4 1626
a=8.7779(3)Å b=9.8015(4)Å c=12.8782(4)Å
α=106.472(2)° β=90.408(2)° γ=91.071(2)°
C19H23FN3O3,C2H2O2,C2HO2
C19H23FN3O3,C2H2O2,C2HO2
Crystal Growth & Design (2013) 13, 4 1626
a=6.9067(7)Å b=13.4563(14)Å c=13.6479(13)Å
α=119.469(4)° β=100.139(5)° γ=92.049(6)°
(E)-bis(3-fluorophenyl)diazene
C12H8F2N2
Crystal Growth & Design (2013) 13, 11 4803
a=7.1516(6)Å b=5.8580(5)Å c=12.2714(10)Å
α=90° β=108.672(5)° γ=90°
(E)-bis(4-fluorophenyl)diazene
C12H8F2N2
Crystal Growth & Design (2013) 13, 11 4803
a=3.8035(4)Å b=5.8716(5)Å c=22.123(2)Å
α=90° β=91.260(7)° γ=90°
(E)-bis(2-fluorophenyl)diazene
C12H8F2N2
Crystal Growth & Design (2013) 13, 11 4803
a=9.779(2)Å b=3.7350(7)Å c=13.188(3)Å
α=90° β=95.492(9)° γ=90°
(E)-bis(4-chlorophenyl)diazene
C12H8Cl2N2
Crystal Growth & Design (2013) 13, 11 4803
a=9.7663(10)Å b=4.6720(5)Å c=11.4452(13)Å
α=90° β=91.138(7)° γ=90°
(E)-bis(3-chlorophenyl)diazene
C12H8Cl2N2
Crystal Growth & Design (2013) 13, 11 4803
a=12.7716(12)Å b=3.8032(4)Å c=11.6316(11)Å
α=90° β=105.903(2)° γ=90°
(E)-bis(2-chlorophenyl)diazene
C12H8Cl2N2
Crystal Growth & Design (2013) 13, 11 4803
a=11.4948(10)Å b=3.8134(3)Å c=13.5210(11)Å
α=90° β=113.889(2)° γ=90°
(E)-bis(4-bromophenyl)diazene
C12H8Br2N2
Crystal Growth & Design (2013) 13, 11 4803
a=10.0896(19)Å b=4.7532(10)Å c=11.622(2)Å
α=90° β=91.951(4)° γ=90°
(E)-bis(3-bromophenyl)diazene
C12H8Br2N2
Crystal Growth & Design (2013) 13, 11 4803
a=10.9225(8)Å b=4.4318(3)Å c=11.9113(9)Å
α=90° β=98.145(3)° γ=90°
(E)-bis(2-bromophenyl)diazene
C12H8Br2N2
Crystal Growth & Design (2013) 13, 11 4803
a=21.7149(10)Å b=3.9697(2)Å c=13.7591(7)Å
α=90° β=105.101(3)° γ=90°